Pathophysiology of Endovascular Resuscitation
Type
AdditionConfidence
68%
Created
Mar 28, 2026
Evidence
2 sources
Rationale
Article 1 (Lendrum 2026, PMID 38985496) describes prehospital pREBOA use in exsanguinating subdiaphragmatic hemorrhage — a clinically relevant extension of the existing pREBOA/iREBOA discussion. Although flagged and cohort-level evidence, it adds meaningful context about the prehospital application of partial REBOA, which is not currently addressed in the section. It is integrated with appropriate epistemic hedging. Article 2 (Latif 2023, PMID 37226264) is a review on traumatic hemorrhage and chain of survival that provides useful framing for the opening paragraph, reinforcing the time-critical, systems-level nature of DCR without contradicting existing content. Both additions are modest and match the existing citation density and academic tone of the section.
Evidence
Content Changes
<!-- type: physiology --> Hemorrhagic shock produces progressive **oxygen debt** and a self-reinforcing cycle of hypoperfusion, acidosis, hypothermia, and coagulopathy (“lethal("lethal triad/lethal diamond”).diamond"). Early hemorrhage control and **damage control resuscitation (DCR)** are therefore time-critical. [@rotondo1993] [@spahn2019] The concept of a "chain of survival" in traumatic hemorrhage emphasizes that each link — from prehospital recognition through definitive hemostasis — must be optimized to improve outcomes [@latif2023-b]. **Where endovascular trauma management (EVTM) fits in DCR** EVTM complements DCR by providing **rapid proximal or selective hemorrhage control** (e.g., resuscitative endovascular balloon occlusion of the aorta (REBOA), selective balloon occlusion, embolization, covered stents/stent-grafts) that can shorten time-to-hemostasis and reduce the duration of profound shock while definitive surgical/interventional radiology (IR) control is arranged. [@morrison2014] [@trauma2016-endovascular] However, the clinical benefit of REBOA remains a subject of intense debate; recent evidence from the UK-REBOA randomized clinical trial (RCT) indicated that the addition of REBOA to standard care in the emergency department (ED) did not improve survival and may even increase mortality, potentially due to procedural delays or complications [@jansen2026]. **Physiologic principles of aortic balloon occlusion** - **Complete occlusion (cREBOA):** maximizes proximal perfusion but risks severe distal ischemia, reperfusion injury, and procedural complications such as vascular access site injury or arterial thrombosis; use the **shortest feasible occlusion time** and transition quickly to definitive control. [@bulger2019] [@marcelo2024] - **Partial/intermittent REBOA (pREBOA/iREBOA):** titrated deflation can preserve some distal flow and attenuate metabolic burden compared with continuous complete occlusion, especially as a bridge when definitive hemostasis is not yet achieved. [@sadeghi2018-partial] Prehospital deployment of partial REBOA has been described in select physician-led systems as a means of extending the window for definitive hemorrhage control in exsanguinating subdiaphragmatic injury, though evidence remains limited to small observational series and the technique demands advanced training and careful patient selection [@lendrum2026]. **Endovascular hemostasis and preservation of perfusion** Covered stents and stent-grafts can **exclude arterial disruption while maintaining in-line flow**, which is particularly valuable for junctional vessels (subclavian/axillary/iliac) that are difficult to expose surgically in unstable patients. [@markov2011] Embolization provides distal/branch control (e.g., pelvic arterial bleeding, solid organ injury) and is commonly integrated into pelvic hemorrhage pathways alongside packing and/or REBOA depending on physiology and resource availability. [@coccolini2017-wses] For surgical damage control concepts (packing, abbreviated laparotomy, open abdomen strategy), see [[Damage Control Surgery]] and [[Open Abdomen]]. [@wses2018]